CN Patent

CN107250153A — 氧代羽扇豆烯衍生物

Assigned to ViiV Healthcare UK No 5 Ltd · Expires 2017-10-13 · 9y expired

What this patent protects

阐述了具有药物和生物学影响的性质的化合物、其药物组合物和使用方法。特别地，提供了如式I和II的化合物所代表的作为HIV成熟抑制剂的具有独特抗病毒活性的桦木酸衍生物。这些化合物可用于治疗HIV和艾滋病。

USPTO Abstract

阐述了具有药物和生物学影响的性质的化合物、其药物组合物和使用方法。特别地，提供了如式I和II的化合物所代表的作为HIV成熟抑制剂的具有独特抗病毒活性的桦木酸衍生物。这些化合物可用于治疗HIV和艾滋病。

Drugs covered by this patent

fostemsavir-tromethamine (FOSTEMSAVIR TROMETHAMINE)

Patent Metadata

Patent number: CN107250153A
Jurisdiction: CN
Classification: —
Expires: 2017-10-13
Drug substance claim: No
Drug product claim: No
Assignee: ViiV Healthcare UK No 5 Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.